DEFB103A
Beta-defensin 103
Also known as: D103A_HUMAN, DEFB-3, DEFB103, DEFB103B, DEFB3, HBD-3, HBD3, HBP-3, HBP3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P81534
- Gene
- DEFB103A
- Ensembl
- ENSG00000176797
- Chromosome
- 8
- Canonical length
- 67 aa
- Protein class
- Predicted secreted proteins, Transporters
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Defensins form a family of microbicidal and cytotoxic peptides made by neutrophils. Members of the defensin family are highly similar in protein sequence. This gene encodes defensin, beta 103, which has broad spectrum antimicrobial activity and may play an important role in innate epithelial defense. [provided by RefSeq, Oct 2014]
Canonical amino-acid sequenceUniProt
67 residues, UniProt reviewed canonical sequence.
>P81534|DEFB103A
1 MRIHYLLFAL LFLFLVPVPG HGGIINTLQK YYCRVRGGRC AVLSCLPKEE QIGKCSTRGR
61 KCCRRKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DEFB103A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 9.5 nTPM
Expression across tissuesHPA
Tissue
- vagina: 9.5 nTPM
- salivary gland: 7.6 nTPM
- tonsil: 7.1 nTPM
- esophagus: 6.3 nTPM
- cervix: 4.7 nTPM
- skin: 3.6 nTPM
Single-cell type
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
- astrocytes: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 0.2 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell chemotaxis
- defense response to bacterium
- defense response to Gram-negative bacterium
- defense response to Gram-positive bacterium
- killing by host of symbiont cells
- killing of cells of another organism
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DEFB103A as an antibody target. Whether an autoantibody or antibody against DEFB103A could matter depends on whether native DEFB103A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DEFB103A is annotated as secreted, so native DEFB103A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label DEFB103A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...